BMF-219 Induces Complete Responses in Target Acute Myeloid Leukemia (AML) Patient Population
Initial topline data from COVALENT-101 trial revealed 2 complete responses (CRs) out of 5 relapsed/refractory…
Initial topline data from COVALENT-101 trial revealed 2 complete responses (CRs) out of 5 relapsed/refractory…
Initial topline data from COVALENT-101 trial revealed 2 complete responses (CRs) out of 5 relapsed/refractory…
– Live moderated webcast with members of the GRI Bio management team on Thursday, July…
– Live moderated webcast with members of the GRI Bio management team on Thursday, July…
SAN DIEGO, July 24, 2023 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company…
SAN DIEGO, July 24, 2023 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company…
Dosing of patients completed at the end of February Data Safety Monitoring Board conducted analysis…
Dosing of patients completed at the end of February Data Safety Monitoring Board conducted analysis…
LAKE FOREST, Ill., July 24, 2023 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the…
LAKE FOREST, Ill., July 24, 2023 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the…
All cash deal with Chembio Diagnostics, a US Subsidiary of the French Diagnostics Company BIOSYNEX,…
All cash deal with Chembio Diagnostics, a US Subsidiary of the French Diagnostics Company BIOSYNEX,…
Interim Data Analysis anticipated in Early 2024 MINNEAPOLIS, July 24, 2023 (GLOBE NEWSWIRE) — Panbela…
Interim Data Analysis anticipated in Early 2024 MINNEAPOLIS, July 24, 2023 (GLOBE NEWSWIRE) — Panbela…
The Company to Host a Conference Call and Webcast on August 10, 2023, at 8:30…
The Company to Host a Conference Call and Webcast on August 10, 2023, at 8:30…
These new appointments bring extensive US and international experience in company leadership and development of…
These new appointments bring extensive US and international experience in company leadership and development of…
RiskScore is the first validated risk model that includes breast density, personal/family history and genetic…
RiskScore is the first validated risk model that includes breast density, personal/family history and genetic…